IBDEI07O ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7593,1,4,0)
 ;;=4^D57.1
 ;;^UTILITY(U,$J,358.3,7593,2)
 ;;=^5002309
 ;;^UTILITY(U,$J,358.3,7594,0)
 ;;=D75.1^^42^498^176
 ;;^UTILITY(U,$J,358.3,7594,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7594,1,3,0)
 ;;=3^Polycythemia,Secondary
 ;;^UTILITY(U,$J,358.3,7594,1,4,0)
 ;;=4^D75.1
 ;;^UTILITY(U,$J,358.3,7594,2)
 ;;=^186856
 ;;^UTILITY(U,$J,358.3,7595,0)
 ;;=C90.30^^42^498^179
 ;;^UTILITY(U,$J,358.3,7595,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7595,1,3,0)
 ;;=3^Solitary Plasmacytoma,Not in Remission
 ;;^UTILITY(U,$J,358.3,7595,1,4,0)
 ;;=4^C90.30
 ;;^UTILITY(U,$J,358.3,7595,2)
 ;;=^5001759
 ;;^UTILITY(U,$J,358.3,7596,0)
 ;;=D56.3^^42^498^180
 ;;^UTILITY(U,$J,358.3,7596,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7596,1,3,0)
 ;;=3^Thalassemia Minor
 ;;^UTILITY(U,$J,358.3,7596,1,4,0)
 ;;=4^D56.3
 ;;^UTILITY(U,$J,358.3,7596,2)
 ;;=^340497
 ;;^UTILITY(U,$J,358.3,7597,0)
 ;;=D56.9^^42^498^181
 ;;^UTILITY(U,$J,358.3,7597,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7597,1,3,0)
 ;;=3^Thalassemia,Unspec
 ;;^UTILITY(U,$J,358.3,7597,1,4,0)
 ;;=4^D56.9
 ;;^UTILITY(U,$J,358.3,7597,2)
 ;;=^340606
 ;;^UTILITY(U,$J,358.3,7598,0)
 ;;=M31.1^^42^498^183
 ;;^UTILITY(U,$J,358.3,7598,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7598,1,3,0)
 ;;=3^Thrombotic Microangiopathy
 ;;^UTILITY(U,$J,358.3,7598,1,4,0)
 ;;=4^M31.1
 ;;^UTILITY(U,$J,358.3,7598,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,7599,0)
 ;;=D51.2^^42^498^184
 ;;^UTILITY(U,$J,358.3,7599,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7599,1,3,0)
 ;;=3^Transcobalamin II Deficiency
 ;;^UTILITY(U,$J,358.3,7599,1,4,0)
 ;;=4^D51.2
 ;;^UTILITY(U,$J,358.3,7599,2)
 ;;=^5002286
 ;;^UTILITY(U,$J,358.3,7600,0)
 ;;=D05.92^^42^498^33
 ;;^UTILITY(U,$J,358.3,7600,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7600,1,3,0)
 ;;=3^Carcinoma in Situ Left Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,7600,1,4,0)
 ;;=4^D05.92
 ;;^UTILITY(U,$J,358.3,7600,2)
 ;;=^5001937
 ;;^UTILITY(U,$J,358.3,7601,0)
 ;;=D05.91^^42^498^35
 ;;^UTILITY(U,$J,358.3,7601,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7601,1,3,0)
 ;;=3^Carcinoma in Situ Right Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,7601,1,4,0)
 ;;=4^D05.91
 ;;^UTILITY(U,$J,358.3,7601,2)
 ;;=^5001936
 ;;^UTILITY(U,$J,358.3,7602,0)
 ;;=D05.90^^42^498^31
 ;;^UTILITY(U,$J,358.3,7602,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7602,1,3,0)
 ;;=3^Carcinoma in Situ Breast Unspec,Unspec Type
 ;;^UTILITY(U,$J,358.3,7602,1,4,0)
 ;;=4^D05.90
 ;;^UTILITY(U,$J,358.3,7602,2)
 ;;=^5001935
 ;;^UTILITY(U,$J,358.3,7603,0)
 ;;=D51.0^^42^498^185
 ;;^UTILITY(U,$J,358.3,7603,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7603,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia d/t Intrinsic Factor Deficiency
 ;;^UTILITY(U,$J,358.3,7603,1,4,0)
 ;;=4^D51.0
 ;;^UTILITY(U,$J,358.3,7603,2)
 ;;=^5002284
 ;;^UTILITY(U,$J,358.3,7604,0)
 ;;=D51.1^^42^498^186
 ;;^UTILITY(U,$J,358.3,7604,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7604,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia d/t Selective Vit B12 Malabsorp w/ Proteinuria
 ;;^UTILITY(U,$J,358.3,7604,1,4,0)
 ;;=4^D51.1
 ;;^UTILITY(U,$J,358.3,7604,2)
 ;;=^5002285
 ;;^UTILITY(U,$J,358.3,7605,0)
 ;;=D51.9^^42^498^188
 ;;^UTILITY(U,$J,358.3,7605,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7605,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,7605,1,4,0)
 ;;=4^D51.9
 ;;^UTILITY(U,$J,358.3,7605,2)
 ;;=^5002289
 ;;^UTILITY(U,$J,358.3,7606,0)
 ;;=D68.0^^42^498^190
 ;;^UTILITY(U,$J,358.3,7606,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7606,1,3,0)
 ;;=3^Von Willebrand's Disease
 ;;^UTILITY(U,$J,358.3,7606,1,4,0)
 ;;=4^D68.0
 ;;^UTILITY(U,$J,358.3,7606,2)
 ;;=^127267
 ;;^UTILITY(U,$J,358.3,7607,0)
 ;;=C88.0^^42^498^191
 ;;^UTILITY(U,$J,358.3,7607,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7607,1,3,0)
 ;;=3^Waldenstrom Macroglobulinemia
 ;;^UTILITY(U,$J,358.3,7607,1,4,0)
 ;;=4^C88.0
 ;;^UTILITY(U,$J,358.3,7607,2)
 ;;=^5001748
 ;;^UTILITY(U,$J,358.3,7608,0)
 ;;=C91.02^^42^498^3
 ;;^UTILITY(U,$J,358.3,7608,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7608,1,3,0)
 ;;=3^Acute Lymphoblastic Leukemia,In Relapse
 ;;^UTILITY(U,$J,358.3,7608,1,4,0)
 ;;=4^C91.02
 ;;^UTILITY(U,$J,358.3,7608,2)
 ;;=^5001764
 ;;^UTILITY(U,$J,358.3,7609,0)
 ;;=C92.02^^42^498^6
 ;;^UTILITY(U,$J,358.3,7609,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7609,1,3,0)
 ;;=3^Acute Myeloblastic Leukemia,In Relapse
 ;;^UTILITY(U,$J,358.3,7609,1,4,0)
 ;;=4^C92.02
 ;;^UTILITY(U,$J,358.3,7609,2)
 ;;=^5001791
 ;;^UTILITY(U,$J,358.3,7610,0)
 ;;=D09.3^^42^498^43
 ;;^UTILITY(U,$J,358.3,7610,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7610,1,3,0)
 ;;=3^Carcinoma in Situ of Thyroid/Oth Endocrine Glands
 ;;^UTILITY(U,$J,358.3,7610,1,4,0)
 ;;=4^D09.3
 ;;^UTILITY(U,$J,358.3,7610,2)
 ;;=^5001955
 ;;^UTILITY(U,$J,358.3,7611,0)
 ;;=C22.0^^42^498^84
 ;;^UTILITY(U,$J,358.3,7611,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7611,1,3,0)
 ;;=3^Hepatocellular Carcinoma
 ;;^UTILITY(U,$J,358.3,7611,1,4,0)
 ;;=4^C22.0
 ;;^UTILITY(U,$J,358.3,7611,2)
 ;;=^5000933
 ;;^UTILITY(U,$J,358.3,7612,0)
 ;;=C24.9^^42^498^108
 ;;^UTILITY(U,$J,358.3,7612,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7612,1,3,0)
 ;;=3^Malig Neop Biliary Tract,Unspec
 ;;^UTILITY(U,$J,358.3,7612,1,4,0)
 ;;=4^C24.9
 ;;^UTILITY(U,$J,358.3,7612,2)
 ;;=^5000942
 ;;^UTILITY(U,$J,358.3,7613,0)
 ;;=C50.922^^42^498^132
 ;;^UTILITY(U,$J,358.3,7613,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7613,1,3,0)
 ;;=3^Malig Neop Left Male Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,7613,1,4,0)
 ;;=4^C50.922
 ;;^UTILITY(U,$J,358.3,7613,2)
 ;;=^5133340
 ;;^UTILITY(U,$J,358.3,7614,0)
 ;;=C34.91^^42^498^150
 ;;^UTILITY(U,$J,358.3,7614,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7614,1,3,0)
 ;;=3^Malig Neop Right Bronchus/Lung,Unspec Part
 ;;^UTILITY(U,$J,358.3,7614,1,4,0)
 ;;=4^C34.91
 ;;^UTILITY(U,$J,358.3,7614,2)
 ;;=^5000967
 ;;^UTILITY(U,$J,358.3,7615,0)
 ;;=C50.921^^42^498^154
 ;;^UTILITY(U,$J,358.3,7615,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7615,1,3,0)
 ;;=3^Malig Neop Right Male Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,7615,1,4,0)
 ;;=4^C50.921
 ;;^UTILITY(U,$J,358.3,7615,2)
 ;;=^5001198
 ;;^UTILITY(U,$J,358.3,7616,0)
 ;;=C90.02^^42^498^163
 ;;^UTILITY(U,$J,358.3,7616,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7616,1,3,0)
 ;;=3^Multiple Myeloma,In Relapse
 ;;^UTILITY(U,$J,358.3,7616,1,4,0)
 ;;=4^C90.02
 ;;^UTILITY(U,$J,358.3,7616,2)
 ;;=^5001753
 ;;^UTILITY(U,$J,358.3,7617,0)
 ;;=Z85.818^^42^499^92
 ;;^UTILITY(U,$J,358.3,7617,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7617,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Lip,Oral Cavity & Pharynx
 ;;^UTILITY(U,$J,358.3,7617,1,4,0)
 ;;=4^Z85.818
 ;;^UTILITY(U,$J,358.3,7617,2)
 ;;=^5063439
 ;;^UTILITY(U,$J,358.3,7618,0)
 ;;=Z85.819^^42^499^93
 ;;^UTILITY(U,$J,358.3,7618,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7618,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Lip,Oral Cavity & Pharynx,Unspec
 ;;^UTILITY(U,$J,358.3,7618,1,4,0)
 ;;=4^Z85.819
 ;;^UTILITY(U,$J,358.3,7618,2)
 ;;=^5063440
 ;;^UTILITY(U,$J,358.3,7619,0)
 ;;=Z85.01^^42^499^88
 ;;^UTILITY(U,$J,358.3,7619,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7619,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Esophagus
 ;;^UTILITY(U,$J,358.3,7619,1,4,0)
 ;;=4^Z85.01
 ;;^UTILITY(U,$J,358.3,7619,2)
 ;;=^5063395
 ;;^UTILITY(U,$J,358.3,7620,0)
 ;;=Z85.028^^42^499^99
 ;;^UTILITY(U,$J,358.3,7620,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7620,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Stomach
 ;;^UTILITY(U,$J,358.3,7620,1,4,0)
 ;;=4^Z85.028
 ;;^UTILITY(U,$J,358.3,7620,2)
 ;;=^5063397
 ;;^UTILITY(U,$J,358.3,7621,0)
 ;;=Z85.038^^42^499^90
 ;;^UTILITY(U,$J,358.3,7621,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7621,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Large Intestine
